Merck & Co., Inc.

Peter Thiel is betting big on a $2B AI cow collar startup powered by cowgorithms — and investors are fighting to get in

Halter's smart collars let ranchers herd cattle from their phones. Here's what that means for your portfolio.

Source: Moneywise Mar 22, 2026

Merck’s New GARDASIL Data And What It May Mean For MRK Stock

Merck, NYSE:MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The data highlight vaccine effectiveness against cancers and diseases caused by HPV, alongside updated safety findings. The disclosure includes both clinical and real world evidence on the durability of protection from Merck's GARDASIL vaccine portfolio. For investors watching NYSE:MRK, this update centers on one of Merck's key vaccine franchises rather than...

Source: Simply Wall St. Mar 22, 2026

Big drugmakers saved at least $5bn on US taxes shifting income overseas

Ten of the biggest US pharmaceutical and biotech companies cut at least $5bn from their federal tax bills last year by booking income in low...

Source: Financial Times Mar 20, 2026

H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95

Tempus AI, Inc. (NASDAQ:TEM) is among the 10 Best New AI Stocks to Buy. On March 9, H.C. Wainwright analyst Yi Chen raised the firm’s price target on Tempus AI, Inc. (NASDAQ:TEM) to $95 from $89 while maintaining a Buy rating. The analyst highlighted the company’s expanding network of strategic partnerships, including collaborations with Merck & Co.,

Source: Insider Monkey Mar 20, 2026

'My Dad Lost Everything': Jim Cramer 'Willing To Expose' His Father For Picking The Wrong Stock — And Missing Multimillionaire Opportunity

Jim Cramer has long championed individual stock picking, but he also urges investors to know when to walk away from a losing trade. Speaking on the "Big Technology" podcast with Alex Kantrowitz in December, Cramer said investing in individual stocks isn't easy and requires careful research and attention to major trend shifts. He shared the story of his father, who kept investing in the now-defunct video rental company National Video and ended up losing everything. "My dad lost everything on Nati

Source: Benzinga Mar 20, 2026

iBio Touts Bispecific Antibody Strategy for PH-HFpEF, Eyes Development Candidate in Q3

Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific antibody program that the company believes could become a next-generation therapy for heart failure, with an initial focus on pulmonary hypertension associated with heart failure wit

Source: MarketBeat Mar 20, 2026